Medicinal Effects of Agathosma (Buchu) Extracts
- Barbara Huisamen(editor)
- Patrick J.D. Bouic(author)
- Carmen Pheiffer(author)
- Mignon van Vuuren(author)
| Title | Medicinal Effects of Agathosma (Buchu) Extracts |
|---|---|
| Contributor | Barbara Huisamen(editor) |
| DOI | https://doi.org/10.4102/aosis.2019.BK84 |
| Landing page | https://books.aosis.co.za/index.php/ob/catalog/book/84 |
| License | https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| Copyright | Barbara Huisamen (ed.). Licensee: AOSIS (Pty) Ltd. The moral right of the author has been asserted. |
| Publisher | AOSIS |
| Publication place | Durbanville, Cape Town, South Africa |
| Published on | 2019-08-29 |
| ISBN | 978-1-928396-81-9 (Paperback) |
| 978-1-928396-82-6 (PDF) | |
| 978-1-928396-47-5 (EPUB) | |
| Long abstract | The research results presented in this book span the quest of Cape Kingdom Nutraceuticals, Prof. Patrick Bouic and Prof. Barbara Huisamen to scientifically validate the health-promoting properties of an aqueous extract of the plant Agathosma. To accomplish this, they made use of both in vitro and in vivo models to understand and underscore the anecdotal information of the benefits of this product. Cell-based studies highlighted anti-inflammatory and anti-diabetic effects while animal-based studies were utilized to confirm the anti-diabetic effects whilst further elaborating on anti-obesity properties. In addition, technology aimed at small animals were used to follow blood pressure to demonstrate anti-hypertensive effects while ex vivo perfused hearts were studied to show that this extract also protected the heart against an ischaemic incident. In view of the current pandemic of obesity and non-communicable diseases, the research results presented in this book will be of special interest to the scientific community and health practitioners interested in cardiometabolic diseases and nutraceuticals as an alternative treatment option. In view of the failure of many pharmaceuticals to curb non-communicable diseases, these results are deemed of high importance. |
| Print length | 132 pages (nulla+132+nulla) |
| Language | English (Original) |
| Dimensions | 170 x 244 mm | 6.692913385826772" x 9.606299212598426" (Paperback) |
| Media | 29 illustrations |
| 5 tables | |
| THEMA |
|
| BIC |
|
| Keywords |
|
Contents
- Saartjie Roux
- Barbara Huisamen
- Patrick J.D. Bouic
- Barbara Huisamen
- Barbara Huisamen
- Barbara Huisamen
| Landing Page | Full text URL | Platform | |||
|---|---|---|---|---|---|
| http://books.aosis.co.za/index.php/ob/catalog/book/84(opens in new tab) | Landing page(opens in new tab) | http://books.aosis.co.za/index.php/ob/catalog/book/84(opens in new tab) | Full text URL(opens in new tab) | Publisher Website |
Contributors
Barbara Huisamen
(editor)Barbara Huisamen obtained her PhD from the University of Stellenbosch in 1993, with a dissertation on the characterisation of the inositol trisphosphate receptor of the sarcoplasmic reticulum and its role in handling calcium levels. She continued her research in the Division of Medical Physiology of the Faculty of Medicine and Health Sciences at the Tygerberg Campus of the University of Stellenbosch, where she is currently an emeritus professor. She was also a Chief Specialist Scientist at the SA-MRC Biomedical, Research and Innovation Platform until 31 December 2018. Her preclinical research has 2 main focus areas, namely (1) myocardial insulin signalling in obesity, type 2 diabetes and hypertension and (2) pharmacological or nutraceutical interventions and treatment options to protect and improve pathology.
Prof. Huisamen has published 67 peer-reviewed articles on cardiometabolic diseases and cardioprotection, which drew about 2000 citations from peers. She has presented her work at more than 70 international conferences, also as invited speaker, and at more than 150 national meetings. She has also presented her work as a guest speaker. She holds various patents on the use of nutraceuticals as treatment options in disease states. Prof. Huisamen has a keen interest in training young scientists and has graduated 48 MSc and PhD students in her career to date.
Patrick J.D. Bouic
(author)Patrick J.D. Bouic was trained as an immunopathologist in France and graduated with a PhD from the University of Claude Bernard, Lyon, in 1984. He has been a board-certified immunologist with the HPCSA since 1994 and has been with the University of Stellenbosch Faculty of Medicine and Health Sciences (in the Division of Pathology [Medical Microbiology]) since 1984. As an academic, he lectures to undergraduate students and oversees many postgraduate candidates registered with the university. He was the head of the Diagnostic Immunology Laboratory for 20 years before forming a private company, Synexa Life Sciences, in Cape Town in 2002, where he is one of the founding directors and serves as the Chief Scientific Officer. The company has its headquarters in Cape Town, but also has a laboratory in London and is currently opening a new facility in Berlin. These laboratories provide biomarker support services in Europe for larger pharma companies as well as smaller biotechnology groups.
Prof. Bouic was personally involved in the development of a natural immune supportive supplement (Moducare™), which was launched in the South African market in 2000 and is currently sold globally. He co-authored a book entitled The Immune System Cure with Lorna van den Haege, which received the gold medal for 2 years running as best seller by the Canadian Health Food Association in 2002 and 2003. This book outlines natural remedies that can be used to manage chronic diseases as well as those used to prevent immune conditions linked to the ageing process.
Patrick has a passion for knowledge sharing and to date he has done more than 150 conference presentations, both locally and internationally. He has been widely published (with more than 150 peer-reviewed publications and several book chapters to his credit) and has numerous patents covering new formulations derived from natural sources. He serves on the SAB of Becton Dickinson, an international company that develops reagents and technologies for diagnostics and research purposes.
Carmen Pheiffer
(author)Carmen Pheiffer began her career by studying antibiotic resistance in Enterococcus faecium, whereafter she obtained her MSc degree (with distinction) from the University of Cape Town, studying transcriptional regulation of the gonadotropin-releasing hormone receptor gene. She received a prestigious GSK PhD scholarship to study Mycobacterium tuberculosis protein expression and humoral immune responses of tuberculosis patients, under the supervision of Prof. Paul van Helden. Dr Pheiffer received postdoctoral training in the laboratory of Prof. Gennaro at the Public Health Research Institute, USA. In 2007, she joined the South African Medical Research Council to establish the molecular biology laboratory and coordinate gene and protein expression experiments at the Biomedical Research and Innovation Platform that primarily conducted contract research bound by confidentiality agreements. Her research involves using cell and animal models to investigate the anti-obesity and anti-diabetic potential of indigenous plant extracts. Recently, her research has expanded to include DNA methylation and microRNA regulation during obesity, type 2 diabetes and gestational diabetes in South African women. Dr Pheiffer supervises postgraduate students and has collaborations with scientists from several universities and the Agricultural Research Council.
Mignon van Vuuren
(author)Mignon obtained her PhD in Medical Physiology from the University of Stellenbosch in 2018. Her research involved the link between natural substances and their effects on diabetes, hypertension and cardiovascular health. She was awarded several bursaries during her research career, namely University of Stellenbosch Merit Bursaries for 2014 to 2017, NRF Grant Holder-linked Bursaries respectively for 2015 and 2018, and Harry Crossley Foundation Bursaries for 2016 and 2017. She presented her research work at the Physiology Society of South Africa (PSSA) in 2014, at the University of Stellenbosch Academic Year Day in 2014 and 2016, and at the Biomedical Science Year Day in 2015 and 2017, where she respectively won the best poster presentation award, and the second price in the poster presentation section.
